OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma

Podobne zapisy

• OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer
  od: Montler, Ryan, i wsp.
  Wydane: (2016)
• Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
  od: Duhen, Rebekka, i wsp.
  Wydane: (2021)
• Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis
  od: Kovacsovics-Bankowski, Magdalena, i wsp.
  Wydane: (2013)
• Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
  od: Leidner, Rom, i wsp.
  Wydane: (2021)
• Explant Modeling of the Immune Environment of Head and Neck Cancer
  od: Sharon, Shay, i wsp.
  Wydane: (2021)